Dialysis Clinic Inc
- Assets
- $649.7m
- Revenue
- $727.8m
- Investments
- $50.0m
- Employees
- 6,590
- Location
- Nashville, TN
- Founding
- 03/1972
- Data as of
- 09/2022
- EIN
- 62-0850498
Organization Overview
Dialysis Clinic Inc is located in Nashville, TN. The organization was established in 1972. According to its NTEE Classification (E30) the organization is classified as: Ambulatory & Primary Health Care, under the broad grouping of Health Care and related organizations. As of 09/2023, Dialysis Clinic Inc employed 6,590 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Dialysis Clinic Inc is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 09/2022, Dialysis Clinic Inc generated $727.8m in total revenue. This represents relatively stable growth, over the past 7 years the organization has increased revenue by an average of 2.0% each year. All expenses for the organization totaled $848.6m during the year ending 09/2022. While expenses have increased by 5.0% per year over the past 7 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Since 2015, Dialysis Clinic Inc has awarded 236 individual grants totaling $102,453,301. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2022
Describe the Organization's Mission:
Part 3 - Line 1
TO INITIATE AND PROVIDE COMPREHENSIVE CARE FOR PATIENTS WITH END-STAGE RENAL DISEASE.
Describe the Organization's Program Activity:
Part 3 - Line 4a
THE DIALYSIS DIVISION IS THE PRINCIPAL ACTIVITY OF OUR COMPANY AND IS PRIMARILY INVOLVED WITH PROVIDING KIDNEY DIALYSIS AND RELATED SERVICES FOR INSURED AND UNINSURED PATIENTS. RENAL DIALYSIS IS NOT AN ELECTIVE MEDICAL PROCEDURE, BUT A LIFE-SUSTAINING TREATMENT FOR PEOPLE LIVING WITH KIDNEY FAILURE. PROVIDING THESE MEDICALLY-NECESSARY TREATMENTS FURTHERS OUR EXEMPT PURPOSE OF PROVIDING QUALITY OUTPATIENT CARE FOR ALL PATIENTS WITH END-STAGE RENAL DISEASE, WHICH INCLUDES THE APPLICATION OF COMPANY RESOURCES FOR SCIENTIFIC AND EDUCATIONAL PURPOSES FOR THE PREVENTION, EARLY DETECTION, AND TREATMENT OF RENAL DISEASE. DURING FYE 2023, 2,250,069 DIALYSIS PROCEDURES WERE PERFORMED. A SIGNIFICANT PORTION OF OUR DIALYSIS CHARGES ARE COVERED BY MEDICARE AND STATE MEDICAID PROGRAMS, WHILE THE REMAINING COSTS ARE PAID BY THIRD PARTY INSURERS, AND CHARITY CARE. CHARITY CARE IS PROVIDED TO PATIENTS WHO MEET CERTAIN CRITERIA UNDER OUR CHARITY CARE POLICY WITHOUT CHARGE OR AT AMOUNTS LESS THAN OUR ESTABLISHED RATES.
THE LAB DIVISION PROVIDES SPECIALIZED LABORATORY TESTING AND DIAGNOSTIC PROCEDURES FOR DIALYSIS FACILITIES AND PATIENTS WITH KIDNEY DISEASE AND RENAL FAILURE. A VARIETY OF LABORATORY TESTS TO ANALYZE DIFFUSED TOXINS FROM THE BLOOD ARE NECESSARY TO MONITOR THE CLINICAL COURSE OF PATIENTS AND THE OVERALL EFFECTIVENESS OF RENAL DIALYSIS. THESE TESTS ARE NECESSARY IN THE TREATMENT OF RENAL DISEASE, AND FURTHERS OUR EXEMPT PURPOSE OF PROVIDING QUALITY CARE FOR PATIENTS WITH CHRONIC RENAL DISEASE BY CONTINUALLY IMPROVING OUR PROCESSES IN MEASURING LEVELS OF KIDNEY FUNCTION TO PRODUCE OPTIMAL PATIENT OUTCOMES. FOR FYE 2023, 820,725 PATIENT TESTS WERE PERFORMED.
THE SUPPLY AND PHARMACY DIVISION PROVIDES MEDICAL SUPPLIES, INCLUDING BUT NOT LIMITED TO NUTRITIONAL SUPPLEMENTS, DRUGS, AND HOME DIALYSIS SUPPLIES FOR DCI FACILITIES AND PROVIDES PRESCRIPTION MEDICATIONS FOR DCI EMPLOYEES.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Douglas Johnson MD Vice Chairman | Trustee | 39 | $453,418 |
H Keith Johnson MD Chairman Of The Board | Trustee | 32 | $7,498 |
James Perry Director | Trustee | 9 | $0 |
Ken Johnson Director | Trustee | 1 | $0 |
William E Wood President (thru 03/23) | Officer | 39 | $532,562 |
Stuart Redpath Chief Operating Officer | Officer | 40 | $461,747 |
Outside Vendors & Contractors
| Vendor Name (Service) | Service Year | Compensation |
|---|---|---|
Chg Medical Staffing Inc Staffing Services | 9/29/23 | $5,901,586 |
Wr Newman Associates Construction Services | 9/29/23 | $5,647,061 |
Breakout Capital Llc Staffing Services | 9/29/23 | $5,398,965 |
Invicta Construction Solutions Inc Construction Services | 9/29/23 | $4,802,229 |
Quik Travel Staffing Llc Staffing Services | 9/29/23 | $4,191,605 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $0 |
| All other contributions, gifts, grants, and similar amounts not included above | $0 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $0 |
| Total Program Service Revenue | $708,994,220 |
| Investment income | $2,174,782 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $4,754,769 |
| Net Gain/Loss on Asset Sales | $2,882,661 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $1,296 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $727,825,569 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $9,867,496 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $2,709,476 |
| Compensation of current officers, directors, key employees. | $2,709,476 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $371,884,839 |
| Pension plan accruals and contributions | $8,128,317 |
| Other employee benefits | $43,155,050 |
| Payroll taxes | $22,533,368 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $4,195,799 |
| Fees for services: Accounting | $889,121 |
| Fees for services: Lobbying | $435,760 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $1,794,056 |
| Advertising and promotion | $0 |
| Office expenses | $4,155,230 |
| Information technology | $9,159,906 |
| Royalties | $0 |
| Occupancy | $16,031,528 |
| Travel | $3,960,815 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $42,143 |
| Interest | $632,635 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $30,794,429 |
| Insurance | $3,724,534 |
| All other expenses | $94,272,817 |
| Total functional expenses | $848,633,522 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $56,731,280 |
| Savings and temporary cash investments | $35,951,235 |
| Pledges and grants receivable | $0 |
| Accounts receivable, net | $114,356,784 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $16,976,259 |
| Prepaid expenses and deferred charges | $5,759,940 |
| Net Land, buildings, and equipment | $357,037,193 |
| Investments—publicly traded securities | $6,641,105 |
| Investments—other securities | $49,987,692 |
| Investments—program-related | $0 |
| Intangible assets | $4,416,294 |
| Other assets | $1,851,073 |
| Total assets | $649,708,855 |
| Accounts payable and accrued expenses | $22,501,853 |
| Grants payable | $0 |
| Deferred revenue | $0 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $95,904,577 |
| Total liabilities | $118,406,430 |
| Net assets without donor restrictions | $0 |
| Net assets with donor restrictions | $0 |
| Capital stock or trust principal, or current funds | -$85,552,946 |
| Paid-in or capital surplus, or land, building, or equipment fund | $751,580 |
| Retained earnings, endowment, accumulated income, or other funds | $616,103,791 |
| Total liabilities and net assets/fund balances | $649,708,855 |
Grants Awarded
Over the last fiscal year, Dialysis Clinic Inc has awarded $8,603,697 in support to 18 organizations.
| Grant Recipient | Amount |
|---|---|
AMERICAN KIDNEY FUND PURPOSE: DONATION FOR GENERAL SUPPORT | $4,000,000 |
INDIANA UNIVERSITY PURPOSE: MEDICAL RESEARCH RELATED TO KIDNEY FUNCTION | $167,906 |
VANDERBILT UNIVERSITY MEDICAL CENTER PURPOSE: MEDICAL RESEARCH RELATED TO KIDNEY FUNCTION | $120,000 |
STONY BROOK FOUNDATION INC PURPOSE: MEDICAL RESEARCH RELATED TO KIDNEY FUNCTION | $199,612 |
RUTGERS UNIVERSITY FOUDATION PURPOSE: MEDICAL RESEARCH RELATED TO KIDNEY FUNCTION | $149,167 |
UC HEALTH FOUNDATION PURPOSE: MEDICAL RESEARCH RELATED TO KIDNEY FUNCTION | $435,000 |